622 related articles for article (PubMed ID: 15108059)
21. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
Liu XH; Kirschenbaum A; Yao S; Levine AC
Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
[TBL] [Abstract][Full Text] [Related]
23. Enamel matrix derivative promotes osteoclast cell formation by RANKL production in mouse marrow cultures.
Otsuka T; Kasai H; Yamaguchi K; Nishihara T
J Dent; 2005 Oct; 33(9):749-55. PubMed ID: 16199283
[TBL] [Abstract][Full Text] [Related]
24. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
[TBL] [Abstract][Full Text] [Related]
26. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
[TBL] [Abstract][Full Text] [Related]
27. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.
Kobayashi Y; Hashimoto F; Miyamoto H; Kanaoka K; Miyazaki-Kawashita Y; Nakashima T; Shibata M; Kobayashi K; Kato Y; Sakai H
J Bone Miner Res; 2000 Oct; 15(10):1924-34. PubMed ID: 11028444
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
30. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption.
Wise GE; Yao S; Zhang Q; Ren Y
Arch Oral Biol; 2002 Mar; 47(3):247-54. PubMed ID: 11839361
[TBL] [Abstract][Full Text] [Related]
32. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition.
Kanzaki H; Chiba M; Shimizu Y; Mitani H
J Dent Res; 2001 Mar; 80(3):887-91. PubMed ID: 11379890
[TBL] [Abstract][Full Text] [Related]
33. Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism.
Gruber R; Karreth F; Fischer MB; Watzek G
Bone; 2002 May; 30(5):726-32. PubMed ID: 11996911
[TBL] [Abstract][Full Text] [Related]
34. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
36. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
37. RANKL-RANK signaling in osteoclastogenesis and bone disease.
Wada T; Nakashima T; Hiroshi N; Penninger JM
Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
[TBL] [Abstract][Full Text] [Related]
38. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells.
Hasegawa T; Yoshimura Y; Kikuiri T; Yawaka Y; Takeyama S; Matsumoto A; Oguchi H; Shirakawa T
J Periodontal Res; 2002 Dec; 37(6):405-11. PubMed ID: 12472833
[TBL] [Abstract][Full Text] [Related]
39. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
40. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
